New Publication
Clinical, Immunological, Radiographic, and Pathologic Improvements in a Patient with Long-Standing Crohn’s Disease After Receiving Stem Cell Educator Therapy
Berlin Presentation
Dr. Yong Zhao presented Stem Cell Educator therapy at the 15th World Congress on Targeting Mitochondria in Berlin.
Breaking News
Reuter’s Global Health Initiative awards Throne Biotechnologies as one of the top 3 biotech companies in 2025.
New Publication
Increase in the Expression of Glucose Transporter 2 on the Peripheral Blood Insulin-Producing Cells in Type 1 Diabetic Patients
Successfully treat a Patient with Long-Standing Crohn’s Disease with Stem Cell Educator Therapy
Throne is pleased to announce that Dr. Yong Zhao and his team published a new clinical Communication in the International Journal of Molecular Sciences (ijms), titled “Clinical, Immunological, Radiographic, and Pathologic
Breaking News: Reuter’s Global Health Initiative awarded Throne Biotechnologies as one of the top 3 biotech companies in 2025
Throne Biotechnologies (Throne) has been awarded as one of top three biotech companies in the Reuters’ Global Health Initiative, which distributes the Throne’s documentary film on Reuters.com. Dr. Yong Zhao, founder
Dr. Yong Zhao presented Stem Cell Educator therapy at the 15th World Congress on Targeting Mitochondria in Berlin
Paramus, New Jersey (Nov.11, 2024) – The 15th World Mitochondria Society (WMS) Annual Meeting on Targeting Mitochondria, was held on October 29-31, 2024 in Berlin, Germany. Dr. Yong Zhao was
New Publication: Increase in the Expression of Glucose Transporter 2 on the Peripheral Blood Insulin-Producing Cells in Type 1 Diabetic Patients After Receiving Stem Cell Educator Therapy
We are pleased to announce that Dr. Yong Zhao and his team published a new clinical research manuscript in the International Journal of Molecular Sciences (ijms), titled “Increase in the
Throne Welcomes Renowned Ophthalmologist, Dr. Robin Ross, as Director of Ophthalmology
Here at Throne Biotechnologies, we are pleased to announce Dr. Robin Ross, M.D., MPH, CPH as our Director of Ophthalmology. Dr. Ross is the Board Certified American Board of Ophthalmology
Throne Received FDA Approval on Regenerative Medicine Advanced Therapy (RMAT) Designation by Using Stem Cell Educator Therapy to Treat Type 1 Diabetes
Paramus, New Jersey (April 24, 2024) – Throne Biotechnologies is one of the global-leading biotech companies aiming to find a cure for type 1 diabetes. We are excited to announce